Back to search

University of Leeds

Targeting the essential interactions of the M2-1 protein of human respiratory syncytial virus (HRSV) for anti-viral drug development

Abstract

dc:description.abstract

Human respiratory syncytial virus (HRSV) is a non-segmented negative stranded RNA virus classified within the Mononegavirales order. HRSV is the leading cause of lower respiratory tract illness in young children and the immunocompromised, with over 250,000 annual fatalities worldwide. HRSV-mediated diseases are especially prevalent in developing countries, where no financially viable treatment exists. The M2-1 protein of HRSV represents a promising potential anti-viral target for the treatment of HRSV-mediated diseases. M2-1 is a transcription antiterminator with an essential role in viral gene expression. M2-1 binds both viral RNA and the polymerase co-factor phosphoprotein (P), and these interactions are essential for its anti-termination activity. Here, the crystal structure of M2-1 in complex with a P protein peptide was determined and used in addition to the unbound M2-1 crystal structure as a basis to identify potential anti-viral compounds. Structure based drug design (SBDD) of M2-1s interaction interface with RNA/ P produced hit compounds that were analysed through biophysical, structural and in cellulo methods including the use of a mini-genome and infectious HRSV assay. SBDD identified hit compounds that significantly inhibited the growth of HRSV. Subsequently, synthetic chemistry was used to generate libraries of molecules to establish structure-activity relationships (SAR) as well as assess their pharmacokinetic properties. Further, a novel facility that allowed assessment of fragment binders to HRSV M2-1 by X-ray crystallography was utilised to determine hit binders towards the entire M2-1 protein, including the previously targeted RNA/ P surface and allowed further rapid SAR. The work presented here represents an effective strategy to rationally design anti-viral compounds for the M2-1 protein of HRSV with potential applications for the related virus, bovine respiratory syncytial virus (BRSV).

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Dods, Rachel Linda
Advisor dc:contributor.advisor
  • Barr, John N

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.736482

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Dods, Rachel Linda. Targeting the essential interactions of the M2-1 protein of human respiratory syncytial virus (HRSV) for anti-viral drug development. doctoral thesis, University of Leeds, 2017.